Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States.
Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA 3rd, Casablanca Y, Washington C, Chappell NP, Klopp AH, Shriver CD, Tarney CM, Bateman NW, Conrads TP, Maxwell GL, Phippen NT, Darcy KM.
Sitler CA, et al. Among authors: chappell np.
Cancers (Basel). 2024 Mar 6;16(5):1071. doi: 10.3390/cancers16051071.
Cancers (Basel). 2024.
PMID: 38473428
Free PMC article.